, Tracking Stock Market Picks
Enter Symbol:
Centene Corporation (CNC) [hlAlert]

up 253.24 %

Centene Corporation (CNC) rated Overweight with price target $88 by Barclays

Posted on: Monday,  Jun 15, 2015  1:25 PM ET by Barclays

Barclays rated Overweight Centene Corporation (NYSE: CNC) on 06/15/2015. Previously Barclays rated Overweight Centene Corporation (NYSE: CNC) on 07/25/2012., when
the stock price was $17.90. Since then, Centene Corporation has gained 253.24% as of 01/21/2016's recent price of $63.23.
If you would have followed the previous Barclays's recommendation on CNC, you would have gained 253.24% of your investment in 1275 days.

Centene Corporation is a multi-line healthcare enterprise operating primarily in two segments: Medicaid Managed Care and Specialty Services. The Company?s Medicaid Managed Care segment provides Medicaid and Medicaid-related health plan coverage to individuals through government subsidized programs, including Medicaid, the State Children?s Health Insurance Program (SCHIP), Foster Care, Medicare Special Needs Plans and Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD). The Company?s Specialty Services segment provides specialty services, including behavioral health, individual health insurance, life and health management, long-term care programs, managed vision, nurse triage, and pharmacy benefits management to state programs, healthcare organizations, employer groups and other commercial organizations, as well as to its subsidiaries.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/15/2015 1:25 PM Buy
77.70 88.00
as of 8/27/2015
1 Week down  -5.00 %
1 Month down  -20.85 %
3 Months down  -7.23 %
1 YTD up  114.52 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/24/2015 1:25 PM Buy
61.63 66.00
12/15/2014 1:25 PM Buy
51.35 60.00
10/23/2013 1:25 PM Buy
31.79 42.00
1/4/2013 1:25 PM Buy
20.81 30.00
12/3/2012 2:25 PM Buy
22.60 25.50
7/25/2012 12:25 PM Buy
17.90 23.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy